Top Companies in CAR NK-cell Therapy 2023
One of the most promising approaches in cellular therapies is immunotherapies using engineered T cells or natural killer (NK) cells expressing chimeric antigen receptors (CARs). Will CAR-NK cell therapies overshadow traditional CAR-T options for the treatment of some cancers?
As of April 2023, more than 50 studies have been launched to investigate the potential of CAR-NK cell therapy.
What is CAR-NK?NK cells are a part of the innate immune system and are the first line of defense against foreign infections and cancer cells. Their primary role is surveillance, early detection of foreign cells and initial immune system activity. By engineering NK cells with a CAR receptor, they become CAR NK cell therapies.
CAR NK-cell Therapy CompaniesBelow is a list of CAR-NK therapy companies involved with chimeric antigen receptor (CAR-NK) cell technologies.
Some of the companies are developing CAR-NK therapies in-house, while others have invested in, acquired, or partnered with companies developing CAR-NK therapies.